Merck KGaA (MKGAY) recently announced a definitive agreement to acquire Berlin, Germany-based Biochrom AG. Biochrom AG, which specializes in the production and marketing of cell culture media and buffer solutions, posted sales of approximately €13 million in 2011. The company also reported a total workforce of approximately 60 in 2011. The financial terms of the deal were not disclosed. Subject to the necessary regulatory approvals, the transaction is expected to close in the fourth quarter of 2012.
Hot off the Zack's press. Could this be the beginning of a " strategic " buying spree ?